Ryvu Therapeutics S.A. (WSE:RVU)

Poland · Delayed Price · Currency is PLN

23.55

+0.15 (0.64%)

Apr 8, 2026, 5:00 PM CET

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Innovation	67.30M	68.44M	35.41M
Innovation Growth	-1.67%	93.25%	-4.16%
Total	67.30M	68.44M	35.41M
Total Growth	-1.67%	93.25%	-4.16%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Poland	79.00K	56.00K	38.00K	106.00K	156.00K
Poland Growth	41.07%	47.37%	-64.15%	-32.05%	-42.75%
EU Members	61.60M	69.33M	41.66M	24.62M	11.03M
EU Members Growth	-11.14%	66.40%	69.25%	123.15%	-28.27%
Other Countries	573.00K	8.59M	5.16M	14.23M	-
Other Countries Growth	-93.33%	66.38%	-63.73%	-	-
Total	62.25M	77.97M	46.86M	38.95M	11.19M
Total Growth	-20.15%	66.38%	20.32%	248.15%	-28.52%

Source: S&P Global Market Intelligence.